将精准医学应用于喘发作异质性的应用
Carlos Andres Celis-Preciado1, Elsa Ben Hamou Kuijpers2, Sanjay Ramakrishnan3
1Faculté de Médecine et des Sciences de la Santé, Université de Sherbrooke, Sherbrooke, QC, Canada; Internal Medicine-Pulmonary Unit, Hospital Universitario San Ignacio, Bogota, Colombia.
Chest
|November 15, 2025
概括
喘发作是复杂而多样化的. 新的生物标志物策略,包括血液中乙氨基基和Feno测试,可以指导个性化治疗,超越标准护理,改善结果并减少口服皮质类固醇的使用.
科学领域:
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
- 精准医学是一门精准的医学.
背景情况:
- 目前的喘发作管理依赖于70年前的基于症状的方法.
- 标准的口服皮质类固醇 (OCS) 治疗严重发作可能导致不理想的结果和显著的毒性.
- 在喘发作中不分青红白地使用抗生素会导致不良事件和抗菌素耐药性.
研究的目的:
- 审查最近关于喘发作异质性的证据.
- 探索生物标志物引导的喘恶化管理策略.
- 强调需要在喘护理中采取量身定制的方法.
主要方法:
- 关于喘发作异质性的最近研究的综述.
- 基于生物标志物评估的分析 (血液中乙氨基基,芬诺,微生物检测).
- 检查临床试验和生物标记指导管理的观察性研究.
主要成果:
- 喘发作在临床,病因和治疗方面表现出显著的异质性.
- 生物标志物评估改善了评估,并使生物标志物引导的管理能够减少OCS和抗生素使用.
- 独特的炎症特征和呼吸道微生物组失调与喘发作集群有关.
结论:
- 喘发作是复杂的情节,有不同的原因和内型.
- 将生物标志物纳入临床评估对于完善喘恶化管理至关重要.
- 量身定制的精准医学方法可以减少对OCS的依赖,改善患者的治疗结果.
相关概念视频
Asthma-I: Introduction
3.3K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.3K
Asthma-II: Pathophysiology and Classification
4.0K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.0K
Asthma-IV: Diagnostic and Management
3.1K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.1K
Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
Asthma-IV: Nursing Management
3.7K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.7K


